Agomab Therapeutics NV (AGMB) Non-Current Deffered Revenue (2026)
Agomab Therapeutics (AGMB) posted Non-Current Deffered Revenue of $1.3 million for Q2 2026.
Powered by 
Analysis
Agomab Therapeutics NV (AGMB) Non-Current Deffered Revenue (2026) Analysis & Trends
Agomab Therapeutics has reported Non-Current Deffered Revenue for 1 years, with the latest figure at $1.3 million in Q2 2026.
Peer Set
Peer Comparison
API Access
Agomab Therapeutics NV Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();